JetEquities

BrainStorm Announces First Contracted U.S. Clinical Site for Pha

Long
NASDAQ:BCLI   Brainstorm Cell Therapeutics Inc
BCLI: BrainStorm Cell Therapeutics Inc.
2019-02-22 07:30:00
BrainStorm Announces First Contracted U.S. Clinical Site for Phase 2 Progressive MS Study
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.